Mitesco (MITI) Amortization of Deferred Charges (2020 - 2026)

Mitesco's (MITI) quarterly Amortization of Deferred Charges came in at $9127.0 in Q1 2026, down 98.39% on a QoQ basis from $565431.0 in Q1 2022.

Mitesco (MITI) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Mitesco (MITI) has 4 years of Amortization of Deferred Charges data on file, last reported at $9127.0 in Q1 2026.

On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $9127.0 in Q1 2026; TTM through Mar 2026 was $9127.0, a N/A change from a year earlier, with the FY2022 full-year figure at $565431.0, changed N/A from the prior year.
Amortization of Deferred Charges for Q1 2026 stood at $9127.0, down from $565431.0 in the prior quarter.
Over the last five years, Amortization of Deferred Charges for MITI reached as high as $565431.0 in Q1 2022 and fell as low as $9127.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	32.28 Bn	24.97 Bn	662.02 Mn
2	BrightSpring Health Services	14.62 Bn	13.72 Bn	482.22 Mn
3	Healthequity	8.35 Bn	8.08 Bn	256.31 Mn
4	Hinge Health	5.98 Bn	5.67 Bn	154.23 Mn
5	10x Genomics	5.88 Bn	5.34 Bn	106.18 Mn
6	MiniMed	4.50 Bn	4.20 Bn	480.00 Mn
7	Waystar Holding	4.47 Bn	4.41 Bn	216.84 Mn
8	Doximity	3.96 Bn	3.21 Bn	125.97 Mn
9	Privia Health	3.13 Bn	2.71 Bn	-
10	Mitesco	861,250.76	859,717.76	-

Download Data